BioCryst Pharmaceuticals, Inc. (BCRX): Price and Financial Metrics
BioCryst Pharmaceuticals, Inc. (BCRX)
Today's Latest Price: $3.64 USD
0.07 (-1.89%)
Updated Oct 28 10:50am
Add BCRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BCRX Stock Summary
- With a price/sales ratio of 13.78, Biocryst Pharmaceuticals Inc has a higher such ratio than 89.29% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 8 for Biocryst Pharmaceuticals Inc; that's greater than it is for 86.89% of US stocks.
- As for revenue growth, note that BCRX's revenue has grown 327.11% over the past 12 months; that beats the revenue growth of 97.94% of US companies in our set.
- Stocks that are quantitatively similar to BCRX, based on their financial statements, market capitalization, and price volatility, are ALBO, FOLD, STRO, CLSN, and EIDX.
- BCRX's SEC filings can be seen here. And to visit Biocryst Pharmaceuticals Inc's official web site, go to www.biocryst.com.
BCRX Stock Price Chart Interactive Chart >
BCRX Price/Volume Stats
| Current price | $3.64 | 52-week high | $6.29 |
| Prev. close | $3.71 | 52-week low | $1.38 |
| Day low | $3.58 | Volume | 1,401,173 |
| Day high | $3.70 | Avg. volume | 7,300,669 |
| 50-day MA | $3.81 | Dividend yield | N/A |
| 200-day MA | $3.71 | Market Cap | 642.70M |
BioCryst Pharmaceuticals, Inc. (BCRX) Company Bio
Biocryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in rare diseases. The company was founded in 1986 and is based in Durham, North Carolina.
Loading social stream, please wait...